www.iaprd-world-congress.com

XXIV WORLD CONGRESS ON PARKINSON҅S DISEASE AND RELATED DISORDERS

MONTREAL / CANADA

201916 – 19 June

© S

ebas

tien

Lem

yre

FINAL PROGRAM

2

CONGRESS VENUE AND FLOORPLAN

The congress takes place on the 5th floorPalais des Congrès de Montreal1001 Place Jean-Paul-Riopelle / Entrance via Place Riopelle HallMontréal, Québec H2Z 1H2Canada

1 Registration

2 Exhibition Hall 511

3 Oral- Poster exhibition Hall 511 & Hall 512 ABEF

4 Auditorium Hall 510

5 Breakout room I Hall 513 ABC

6 Breakout room II Hall 513 DEF

7 Speakersʼ Center Hall 512 D

3

SESSION OVERVIEW / SUNDAY, 16 JUNE 2019

WLAN/Wi-FiComplimentary Wi-Fi access is available in the Palais des Congrès de Montreal. Network: IAPRD2019, Password: IAPRD2019

Room Hall 510 Hall 513 ABC Hall 513 DEF Exhibition Hall 511 Poster

13:30 – 15:00 Therapeutic Updates I: Parkinson Disease

15:00 – 15:30 Coffee Break

15:00 – 19:00

Poster Exhibition

15:30 – 17:00Therapeutic Updates II: Hyperkinetic Movement

Disorders

17:00 – 17:30 Coffee Break

17:30 – 19:00 Opening Ceremony / Melvin Yahr Lectures

from 19:00 Welcome Reception in the Exhibition Hall 511

Plenary Session

Coffee with the Professor Oral Poster Presentation Internal Sessions Morning Educational / Mentorship Sessions

Parallel Tracks Corporate Sessions Skills Workshops Grand Parade of Movement Disorders

4

SESSION OVERVIEW / MONDAY, 17 JUNE 2019

Visit the congress website at www.iaprd-world-congress.com for the detailed program.

Room Hall 510 Hall 513 ABC Hall 513 DEF Exhibition Hall 511 Poster

07:00 – 07:50 Publications and Grant Writing

How to Examine Hypokinetic Patients

08:00 – 09:30Novel Targeted Therapeutics

in Synucleinopathies and Tauopathies

09:00 – 17:00

Poster Exhibition

09:30 – 11:00 IAPRD Annual General Meeting (full IAPRD members only)

Communicating Bad News with Patients Coffee Break

11:00 – 12:30 Parkinson Disease: Basic Disease Mechanisms

Hypokinetic Disorders Video Session Deep Brain Stimulation

Oral Poster Session I – Parkinson’s Disease:

Basic Science and Genetics

12:30 – 12:45

12:45 – 14:15 Corporate Session I Corporate Session II

14:15 – 15:45Hot Topics: How Technological

Advances Are Changing the World of Experimental Therapeutics

15:45 – 16:15 Coffee Break Coffee with the Professor 1

16:15 – 17:45Practical Management of

Nonmotor Manifestations of Parkinson Disease

Dystonias: From Mechanisms

to TreatmentHuntington Disease and Other Choreas

Oral Poster Session II – Parkinson’s Disease: Imaging & Biomarkers / Other Parkinsonian

Disorders

17:45 – 19:15Botulinum Toxins

Supported by US WorldMeds with an unrestricted grant

Practical Nonsurgical Management

Hyperkinetic Disorders Video Session

Oral Poster Session III –Parkinson’s Disease: Clinical

Science, Therapeutics, Surgical Management

Plenary Session Parallel Tracks Corporate Sessions Skills Workshops Grand Parade of Movement Disorders

5

SESSION OVERVIEW / TUESDAY, 18 JUNE 2019

Visit the congress website at www.iaprd-world-congress.com for the detailed program.

Room Hall 510 Hall 513 ABC Hall 513 DEF Exhibition Hall 511 Poster

07:00 – 07:50 How to Start an Academic Career How to Examine Hyperkinetic Patients

08:00 – 09:30Biomarkers in Movement

Disorders: 2019 Update and New Frontiers

09:00 – 17:00

Poster Exhibition

09:30 – 10:30 Coffee Break Learning Effective Presentation Skills Coffee Break

10:30 – 12:00 Infusion Therapies in Parkinson Disease

Tauopathies Ataxia, Tremor and Autoimmune Disorders

Oral Poster Session IV – Parkinson’s Disease:

Clinical Science, Therapeutics, Surgical Management

12:00 – 12:15

12:15 – 13:45 Corporate Session III

13:45 – 15:15Clinical Applications of

Genetic Advances in Movement Disorders

15:15 – 15:45 Coffee Break Coffee with the Professor 2

15:45 – 17:15 Multiple System Atrophy Pediatric Movement Disorders

Neurology Meets Psychiatry

Oral Poster Session V – Hyperkinetic and Other

Movement Disorders

17:15 – 18:00PD Psychosis, Should We Intervene

Early and Does Timing Matter? Supported by an unrestricted grant from

Acadia Pharmaceuticals

18:00 – 20:00Come Together Reception

and Grand Parade of Movement Disorders

Coffee with the Professor Oral Poster Presentation Internal Sessions Morning Educational / Mentorship Sessions

6

SESSION OVERVIEW / WEDNESDAY, 19 JUNE 2019

GENERAL INFORMATION / GOOD TO KNOW

Abstract E-BookThe abstract book contains all accepted abstracts that have been sub-mitted by authors from around the globe on topics related to Parkin-son disease and other movement disorders. All abstracts have been reviewed by a panel of reviewers and are now provided as download on the congress website.

Room Hall 510

08:00 – 10:00 Advanced Therapeutics in Movement Disorders

10:00 – 10:30 Coffee Break

10:30 – 11:30 Debates

11:30 – 12:40

Best Papers in Parkinsonism and Related

Disorders Journal and 2019 IAPRD

Congress Awards

Plenary Session

Coffee with the Professor Oral Poster Presentation Internal Sessions Morning Educational / Mentorship Sessions

Parallel Tracks Corporate Sessions Skills Workshops Grand Parade of Movement Disorders

CloakroomA cloakroom is available on Sunday 16 June and Wednesday 19 June 2019 on ground floor entrance Place Riopelle Hall. You can also store your luggage here.

7

GENERAL INFORMATION / GOOD TO KNOW

CME AccreditationThe XXIV IAPRD World Congress is accredited by the European Accreditation Council for Continuing Medical Education (EACCME®) to provide the following CME activity for medical specialists and is designated for a maximum of (or for up to) 20 hours of European external CME credits. The Congress is also seeking Canadian CME accreditation. For further details please check our website at https://www.iaprd-world-congress.com/scientific-programm/cme-accreditation.

Coffee breaksCoffee and tea are provided during the breaks in the exhibition area and gratefully supported by Sunovion Pharmaceuticals Inc.

Congress Registration CounterAll congress materials and documentations will be available from the congress registration counter located on 5th floor Foyer 510 at the Palais des Congrès de Montreal.

Opening Hours of the Congress Registration CounterSunday, 16 June 2019 11:30 – 19:00Monday, 17 June 2019 07:00 – 19:00Tuesday, 18 June 2019 07:00 – 20:00Wednesday, 19 June 2019 07:30 – 13:00

During these opening hours, the registration counter can be reached at +001 541-789-3400

DisclaimerThe Organizers cannot accept liability for injuries or losses of what-ever nature incurred by participants, nor for loss of or damage to their luggage and/or personal belongings.

LanguageThe official congress language is English. However, all participants are encouraged to join discussions regardless of their fluency in Eng-lish, as the exchange of ideas and critical evaluation of presentation is the main purpose of the entire Congress.

Name BadgeAll participants are requested to wear their name badges at all times during the congress.

Program ChangesThe Organizers cannot assume liability for any changes in the program due to external unforeseen circumstances.

Speakers’ CenterThe speakers’ center is located in Hall 512 D on 5th floor. Speakers are asked to hand in their CD ROM or USB stick to guarantee slides will open successfully on an on-site PC. Prepare your presentation in 16:9 or 4:3 format (screens are in 16:9 format). Speakers are asked to contact the speakers’ center preferably one day before their pres-entation, at latest 90 minutes prior to the presentation.

Opening Hours of the Speakers’ CenterSunday, 16 June 2019 11:30 – 17:30Monday, 17 June 2019 07:00 – 18:00Tuesday, 18 June 2019 07:00 – 18:00Wednesday, 19 June 2019 07:30 – 11:00

Executive BoardExhibitorsIAPRD Full Members

Other DelegatesFacultyStaff

8

CORPORATE SESSIONS MONDAY, 17 JUNE AND TUESDAY, 18 JUNE 2019

EXHIBITION / SPONSORS

17 June 2019 17 June 2019 18 June 2019Hall 513 ABC / 12:45 – 14:15 Hall 513 DEF / 12:45 – 14:15 Hall 513 ABC / 12:45 – 14:15

Addressing Unmet Needs in Parkinson’s Disease – supported by an unrestricted grant from Sunovion Pharmaceuticals Inc.

Tomorrow does not have to be disrupted – The First and Only Medication Clinically Proven to Reduce Dyskinesia and OFF Time in Patients with Parkinson’s Disease – supported by an unrestricted grant of Adamas Pharmaceuticals, Inc.Chair: Mark Lew, USASpeaker: Robert Hauser, USA

Rajesh Pahwa, USA

Learning Objectives:Discuss the burden of dyskinesia and motor fluctuations in Parkinson’s disease and unmet needs with dopaminergic therapyConsider the role of glutamate in motor fluctuationsExplore an adjunctive therapeutic option to modulate the glutamate pathway

Motor Fluctuations in Parkinson’s Disease: What Are We Missing? – supported by an unrestricted grant from Neurocrine Biosciences, Inc.Chair: Mark Lew, USAChair: Daniel Claassen, USA

Learning Objectives: Discuss the mechanisms of motor fluctuations in Parkinson’s Disease Describe the spectrum of ON/OFF and how motor fluctuations lead to clinical features impacting function and quality of life for patients and caregiversReview current methods in identification and management of motor fluctuations

Welcome, Introductions and Rules of the “Game” – Tanya Simuni, USA

Opportunity 1: Making the case for continued investment in agents for motor and non-motor fluctuations in Parkinson’s disease – Hubert Fernandez, USA

Opportunity 2: Making the case for investing in agents that address dementia in Parkinson’s disease – Irene Litvan, USA

Opportunity 3: Making the case for investing in agents that address psychosis in Parkinson’s disease – Daniel Weintraub, USA

We kindly thank all our sponsors for their support! Sponsors’ names are in alphabetical order:

We are pleased to inform you that the IAPRD Congress 2019 is COMPLIANT in accordance with the principles and standards setout in the MedTech Europe Code of Ethical Business Practice. This decision is posted on www.ethicalmedtech.eu. This event is supported, in part, by funding from industry. All support will be managed in strict accordance with CME/CPD accreditation criteria and standards for commercial support.

This years´s Congress Travel Awards are gratefully supported by the Parkinson’s Foundation and individual supporters.

TM

9

EXHIBITION FLOOR PLAN AND EXHIBITORS (as per 20 May 2019)

Company Booth NoAbbVie Inc. A.02Boston Scientific Neuromodulation B.01Elsevier B.V. B.06Medtronic Canada A.06Merz, Inc. A.05Neurocrine Biosciences, Inc. B.02Parkinson Canada B.03Sunovion Pharmaceuticals Inc A.01Theravance Biopharma US, Inc. B.05

Exhibition opening times:

Sunday, 16 June 2019 15:00 – 20:30Monday, 17 June 2019 09:00 – 18:00Tuesday, 18 June 2019 09:00 – 17:30

Code of TransparencyInterplan publishes the conditions and the scope of the support provided by EFPIA member companies to the IAPRD Congress on a voluntary basis. The publication will be carried out before and during the execution of the Congress.For the industry partners mentioned, we are herewith providing information about their overall support within the framework of the IAPRD Congress 2019.

Meet the Professor

A.03

A.02

A.06 A.05 B.05 B.06 B.07

B.02

B.01

B.03

A.01

STIMVIEW™ Technology makes directional programming intuitive and simple.*

SIMPLY ADVANCED

*One click buttons make directional programming intuitive and simple.

Vercise DBS Lead-only system (before Stimulator is implanted) is MR conditional. An MRI examination can be conducted safely when all instructions in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems are followed.

Material not intended for use in France. NM-393421-AC © 2018 Boston Scientific Corporation or its affiliates. All rights reserved.

PLEASE VISIT US AT BOOTH B.01

NM-393421-AC INTL Gevia and Vercise PC_Ad_IARPD Canada.indd 1 5/15/19 3:53 PM

11

LITTLE BIG THINGS is a trademark of Sunovion Pharmaceuticals Inc.SUNOVION and are registered trademarks of Sumitomo Dainippon Pharma Co., Ltd.Sunovion Pharmaceuticals Inc. is a U.S. subsidiary of Sumitomo Dainippon Pharma Co., Ltd. ©2019 Sunovion Pharmaceuticals Inc. All rights reserved. 04/19 NPC-APL-US-00054-19

Visit the Sunovion Booth

for an immersive and interactive exhibit that

illustrates life with Parkinson’s disease and the

types of OFF episodes that patients experience.

PARKINSON’S

HOUSE CALLPARKINSON’S

HOUSE CALL

MAKE AMAKE A

STIMVIEW™ Technology makes directional programming intuitive and simple.*

SIMPLY ADVANCED

*One click buttons make directional programming intuitive and simple.

Vercise DBS Lead-only system (before Stimulator is implanted) is MR conditional. An MRI examination can be conducted safely when all instructions in the supplemental manual ImageReady™ MRI Guidelines for Boston Scientific DBS Systems are followed.

Material not intended for use in France. NM-393421-AC © 2018 Boston Scientific Corporation or its affiliates. All rights reserved.

PLEASE VISIT US AT BOOTH B.01

NM-393421-AC INTL Gevia and Vercise PC_Ad_IARPD Canada.indd 1 5/15/19 3:53 PM

XXIV WORLD CONGRESS ON PARKINSON҅S DISEASE AND RELATED DISORDERS 2020

07 – 10 June

Congress Organization and organizer of the exhibitionand the sponsoringINTERPLANCongress, Meeting & Event Management AG Office HamburgKaiser-Wilhelm-Strasse 93, 20355 Hamburg, GermanyPhone: +49 40 325092-30/ Fax: +49 40 325092-44E-mail: IAPRD@interplan.de Website: www.interplan.de

Organizer of the scientific conference

IAPRD The International Association of Parkinsonism and Related DisordersVan Eeghenstraat 83, 1071 EX Amsterdam, NetherlandsE-Mail: info@iaprd.org Website: www.iaprd.org

PRAGUE / CZECH REPUBLIC

A  COMPREHENSIVE  EDUCATIONAL  PROGRAM

© M

arke

ta M

acho

va